The Chinese Pharmacopoeia 2025 has introduced significant revisions to the 9101 Guidelines for Validation of Analytical Methods further promoting the application of statistics in analytical method validation.
Assesses continuous manufacturing (CM) in pharma green transition, comparing efficiency gains with traditional production amid tech/regulatory barriers and ESG impacts.
When most of us think of mRNA technology, COVID-19 vaccines instantly come to mind. But mRNA is not just a vaccine superstar, it’s an emerging powerhouse in pharmaceutical innovation.
Hormone-derived peptides like semaglutide ($5.16B Q1 sales) redefine drug development through long-acting engineering. Their clinical success demonstrates the transformative potential of endogenous hormones as therapeutic blueprints.
Apeloa Pharmaceutical has released its first sustainability report. Apeloa’s 2024 Environmental, Social and Governance (ESG) report marks the start of continuous and responsible disclosure into the future.
AdvertisingEmail to: Julia.zhang@imsinoexpo.com
Media CooperationEmail to: Jennifer.Yang@imsinoexpo.com
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!